Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

286 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Anticoagulation Treatment in Cancer-Associated Venous Thromboembolism: Assessment of Patient Preferences Using a Discrete Choice Experiment (COSIMO Study).
Picker N, Lee AY, Cohen AT, Maraveyas A, Beyer-Westendorf J, Mantovani LG, Abdelgawwad K, Fatoba S, Thate-Waschke IM, Bach M, Wilke T. Picker N, et al. Among authors: mantovani lg. Thromb Haemost. 2021 Feb;121(2):206-215. doi: 10.1055/s-0040-1714739. Epub 2020 Sep 2. Thromb Haemost. 2021. PMID: 32877956 Free PMC article.
Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study.
Ageno W, Mantovani LG, Haas S, Kreutz R, Monje D, Schneider J, van Eickels M, Gebel M, Zell E, Turpie AG. Ageno W, et al. Among authors: mantovani lg. Lancet Haematol. 2016 Jan;3(1):e12-21. doi: 10.1016/S2352-3026(15)00257-4. Epub 2015 Dec 8. Lancet Haematol. 2016. PMID: 26765643
Predictive value of venous thromboembolism (VTE)-BLEED to predict major bleeding and other adverse events in a practice-based cohort of patients with VTE: results of the XALIA study.
Klok FA, Barco S, Turpie AGG, Haas S, Kreutz R, Mantovani LG, Gebel M, Herpers M, Bugge JP, Kostantinides SV, Ageno W. Klok FA, et al. Among authors: mantovani lg. Br J Haematol. 2018 Nov;183(3):457-465. doi: 10.1111/bjh.15533. Epub 2018 Aug 19. Br J Haematol. 2018. PMID: 30123981 Free PMC article. Clinical Trial.
Characteristics and Management of Patients with Venous Thromboembolism: The GARFIELD-VTE Registry.
Ageno W, Haas S, Weitz JI, Goldhaber SZ, Turpie AGG, Goto S, Angchaisuksiri P, Nielsen JD, Kayani G, Pieper KS, Schellong S, Bounameaux H, Mantovani LG, Prandoni P, Kakkar AK; GARFIELD-VTE investigators. Ageno W, et al. Among authors: mantovani lg. Thromb Haemost. 2019 Feb;119(2):319-327. doi: 10.1055/s-0038-1676611. Epub 2018 Dec 28. Thromb Haemost. 2019. PMID: 30593086
XALIA-LEA: An observational study of venous thromboembolism treatment with rivaroxaban and standard anticoagulation in the Asia-Pacific, Eastern Europe, the Middle East, Africa and Latin America.
Kreutz R, Mantovani LG, Haas S, Monje D, Schneider J, Bugge JP, Gebel M, Tamm M, Ageno W, Turpie AGG. Kreutz R, et al. Among authors: mantovani lg. Thromb Res. 2019 Apr;176:125-132. doi: 10.1016/j.thromres.2019.02.010. Epub 2019 Feb 13. Thromb Res. 2019. PMID: 30825694 Free article. Clinical Trial.
286 results